Catalyst Biosciences Inc buy Wedbush
Start price
14.07.25
/
50%
€0.52
Target price
14.07.26
€23.10
Performance (%)
-
End price
15.07.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by Wedbush for this prediction
In the thread Catalyst Biosciences Inc diskutieren
Crescent Biopharma, Inc. (NASDAQ: CBIO) is now covered by analysts at Wedbush. They set an "outperform" rating and a $27.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
In the thread Trading Catalyst Biosciences Inc
Die von Wedbush gewählte maximale Laufzeit wurde überschritten